Avanos Medical (AVNS) Operating Income (QoQ) (2013 - 2026)
Avanos Medical (AVNS) Operating Income (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 256.00% |
| Dec 31, 2025 | 2,400.00% |
| Sep 30, 2025 | 100.13% |
| Jun 30, 2025 | -823.30% |
| Mar 31, 2025 | 102.46% |
| Dec 31, 2024 | -3,587.50% |
| Sep 30, 2024 | 90.48% |
| Jun 30, 2024 | 57.50% |
| Mar 31, 2024 | -64.29% |
| Dec 31, 2023 | 833.33% |
| Sep 30, 2023 | 157.14% |
| Jun 30, 2023 | 65.57% |
| Mar 31, 2023 | -136.75% |
| Dec 31, 2022 | 29.69% |
| Sep 30, 2022 | 26.73% |
| Jun 30, 2022 | 17.44% |
| Mar 31, 2022 | 138.39% |
| Dec 31, 2021 | -758.82% |
| Sep 30, 2021 | 146.58% |
| Jun 30, 2021 | 41.13% |